|
PUM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.362700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.619400E-04 |
| Normal-vs-Stage2 |
4.711600E-01 |
| Normal-vs-Stage3 |
4.707200E-01 |
| Normal-vs-Stage4 |
8.601000E-01 |
| Stage1-vs-Stage2 |
2.402200E-01 |
| Stage1-vs-Stage3 |
1.732950E-01 |
| Stage1-vs-Stage4 |
3.294400E-01 |
| Stage2-vs-Stage3 |
9.797200E-01 |
| Stage2-vs-Stage4 |
6.487000E-01 |
| Stage3-vs-Stage4 |
6.564600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.456900E-03 |
| Normal-vs-AfricanAmerican |
7.355900E-02 |
| Normal-vs-Asian |
7.733400E-01 |
| Caucasian-vs-AfricanAmerican |
6.844000E-01 |
| Caucasian-vs-Asian |
5.340000E-01 |
| AfricanAmerican-vs-Asian |
6.033400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.601800E-04 |
| Normal-vs-Female |
8.517400E-01 |
| Male-vs-Female |
6.962800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.913600E-02 |
| Normal-vs-Extreme_Weight |
3.581700E-04 |
| Normal-vs-Obese |
4.524600E-01 |
| Normal-vs-Extreme_Obese |
7.123900E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.998400E-01 |
| Normal_Weight-vs-Obese |
1.934380E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.672800E-01 |
| Extreme_Weight-vs-Obese |
1.891800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.338000E-01 |
| Obese-vs-Extreme_Obese |
2.103600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.917600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.648000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.7465999999986E-05 |
| Normal-vs-Age(81-100Yrs) |
3.564700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.842400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.957800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.180500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.567100E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.388400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.160600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.385840E-02 |
| Normal-VS-Type2 PRCC |
6.49779999999378E-05 |
| Normal-VS-KIRP CIMP |
4.715200E-01 |
| Normal-VS-Unclassified PRCC |
8.502200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.743620E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.184100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.979800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.044460E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.785600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.080600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.69217999999027E-05 |
| Normal-vs-N1 |
3.654800E-01 |
| Normal-vs-N2 |
1.480810E-01 |
| N0-vs-N1 |
5.142500E-03 |
| N0-vs-N2 |
4.798000E-01 |
| N1-vs-N2 |
3.557600E-01 |
|
|
